Berkeley Heights, NJ, United States of America

Harry R Davis

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 236(Granted Patents)


Company Filing History:


Years Active: 1993-2021

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Harry R. Davis**

Introduction

Harry R. Davis, an accomplished inventor hailing from Berkeley Heights, NJ, has made significant strides in the field of biomedical innovations, particularly focusing on diabetes treatment and cholesterol absorption. With a portfolio of 14 patents, his work addresses critical health challenges, propelling advancements in medical therapeutics.

Latest Patents

Among his recent patents, Davis has disclosed groundbreaking methods for treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor. This innovative approach aims to enhance the management of diabetes and related conditions, offering new hope for effective treatment options.

Additionally, his patent on the use of azetidinone compounds presents them as inhibitors of cholesterol absorption, proving to be instrumental in discovering and characterizing proteins involved in the trafficking and absorption of cholesterol in biological systems. These compounds not only hold promise in furthering research but also serve as tools for competitive binding assays to uncover other beneficial agents that may act as cholesterol absorption inhibitors.

Career Highlights

Throughout his career, Harry R. Davis has been associated with esteemed pharmaceutical companies, notably Schering Corporation and Merck Sharp & Dohme Corporation. His extensive experience in these organizations has undoubtedly contributed to his expertise and innovative output in the field.

Collaborations

Davis has collaborated with respected professionals in the field, including Scott W. Altmann and Duane A. Burnett. These partnerships underscore the importance of interdisciplinary teamwork in driving forward innovative solutions and enhancing the development of effective medical therapies.

Conclusion

Harry R. Davis stands as a notable figure in the realm of biomedical innovations. His extensive work in diabetes treatment and cholesterol absorption inhibitors not only showcases his impressive range of patents but also highlights his commitment to improving health outcomes. Through his endeavors, he continues to inspire future innovations in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…